CN102441093A - Medicine for lowering transplant renal arterial resistance index - Google Patents
Medicine for lowering transplant renal arterial resistance index Download PDFInfo
- Publication number
- CN102441093A CN102441093A CN2011103852762A CN201110385276A CN102441093A CN 102441093 A CN102441093 A CN 102441093A CN 2011103852762 A CN2011103852762 A CN 2011103852762A CN 201110385276 A CN201110385276 A CN 201110385276A CN 102441093 A CN102441093 A CN 102441093A
- Authority
- CN
- China
- Prior art keywords
- medicine
- gram
- resistance index
- renal arterial
- arterial resistance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medicine for lowering transplant renal arterial resistance index. The invention aims to screen out natural Chinese medicinal herbs capable of clearing away heat and toxic material and activating blood circulation to dissipate blood stasis in reference to modern pharmacological research on the basis of the recognition on the pathogenesis of increase of transplant renal arterial resistance index in the traditional Chinese medicine as well as the principle of treatment. The medicine is prepared from 12g of saffron, 16g of Paris polyphylla, 12g of isatis leaf, 12g of Baikal skullcap root, 15g of Fructus Forsythiae, 15g of red paeonia, 10g of pseudo-ginseng, 15g of tuckahoe and 15g of cortex moutan. The components are evenly mixed, pulverized into 200-mesh fine powder, and packaged into bags (5g for each bag).
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to a kind of medicine that reduces the transplanted kidney drag index, is the Chinese patent medicine of feedstock production specifically with the Chinese herbal medicine.
Background technology transplanted kidney tremulous pulse drag index increases the generation that is often indicating the kidney rejection, if inappropriate treatment transplanted kidney possibly the edema necrosis will occur.At present, it is more to treat this sick medicine, but is the Western medicine immunosuppressant mostly.It is obvious to all that immunosuppressant is taken the side effect that is brought for a long time, directly influences people's physical and mental health, directly brings spirit and burden economically for patient and family.Chinese medicine discovers that the Chinese medicine of heat-clearing and toxic substances removing and blood circulation promoting and blood stasis dispelling share reducing the effectively reduction effect rapidly of transplanted kidney tremulous pulse drag index; This is because the Chinese medicine of heat-clearing and toxic substances removing has the immunosuppressant effect, and the Chinese medicine of blood circulation promoting and blood stasis dispelling can improve the blood supply function of transplanted kidney.
It is the medicine of the reduction transplanted kidney drag index of the rule of treatment with heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling that summary of the invention the purpose of this invention is to provide a kind of, to overcome the deficiency of prior art.
The objective of the invention is the pathogenetic understanding and the Therapeutic Principle thereof that the transplanted kidney drag index are increased according to motherland's medical tradition medical science; With reference to modern pharmacological research; Therefrom filter out the natural Chinese medicinal herb of heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling; By the theory of Chinese medical science prescription, make its performance reduce the effect of transplanted kidney drag index.
Medicine of the present invention is processed by following component:
Stigma Croci 12 gram Rhizoma Paridis 16 gram Folium Isatidiss 12 gram Radix Scutellariaes 12 gram Fructus Forsythiaes 15 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Poria 15 gram Cortex Moutans 15 grams
Above-mentioned each component mix homogeneously is ground into 200 order fine powders, is distributed into bag, every packed medicated powder 5 grams.One after each meal, two bags of every days, warm boiled water at twice.
Medicine of the present invention is a Chinese medicine preparation, and is theoretical according to traditional Chinese medical science prescription, select medicine rationally, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, treating both the principal and secondary aspects of a disease.Medicine of the present invention, warp is the clinical observation patient for many years, and is evident in efficacy, and the patient that the transplanted kidney drag index is raise has remarkable result.
Clinical drug of the present invention is taken the result and shown, following advantage is arranged: it is raw material that the present invention selects natural plant for use, and each component meets the pharmaceutical control law regulation; Utilize the comprehensive function treatment transplanted kidney drag index of the medicine of respectively distinguishing the flavor of to raise, no chemicals, harmless to human non-toxic; Have no side effect, safe and reliable.The present invention is a powder, and effective ingredient scatters and disappears few, and curative effect is high, and is cheap, taking convenience, no any discomfort disease.
Be the therapeutic effect that shows that medicine of the present invention raises to the transplanted kidney drag index; The patient that the present invention raises through 100 routine transplanted kidney drag indexs does the clinical observation of system; And select medical history, the state of an illness, age and transplanted kidney drag index rising patient 100 examples suitable to organize as a comparison with traditional therapy (Western medicine immunosuppressant); Age 19-57 year, course of disease 1-9; Test group: take medicine of the present invention; Matched group: Western medicine immunosuppressant.Observation period is one month, check after month, and transplanted kidney drag index＜0.65 is a produce effects, transplanted kidney drag index＜0.70 is that effectively transplanted kidney drag index＞0.70 is invalid.Clinical comparison result sees table 1.
Table 1: take medicine of the present invention with the observation of curative effect of Western medicine immunosuppressant to transplanted kidney drag index rising patient.
Two groups of effective percentage of table 1 relatively
Annotate: curative effect relatively adopts statistical method, and enumeration data adopts X
2Check, two groups of effective percentage compare P＜0.05
Can find out that from table 1 two groups of effective percentage compare: the experimental group total effective rate is 100%, and matched group is 40%, and experimental group obviously is superior to matched group (P＜0.05)
The specific embodiment:
Choose raw material by following proportioning: Stigma Croci 12 gram Rhizoma Paridis 16 gram Folium Isatidiss 12 gram Radix Scutellariaes 12 gram Fructus Forsythiaes 15 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Poria 15 gram Cortex Moutans 15 grams
Above-mentioned each component mix homogeneously is ground into 200 order fine powders, is distributed into bag, every packed medicated powder 5 grams.One after each meal, two bags of every days, warm boiled water at twice.
Claims (1)
1. a medicine that reduces transplanted kidney tremulous pulse drag index is characterized in that it is the powder of being processed by the following weight proportion raw material: Stigma Croci 12 gram Rhizoma Paridis 16 gram Folium Isatidiss 12 gram Radix Scutellariaes 12 gram Fructus Forsythiaes 15 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Poria 15 gram Cortex Moutans 15 grams; Above-mentioned each component mix homogeneously is ground into 200 order fine powders; Be distributed into bag, every packed medicated powder 5 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103852762A CN102441093A (en) | 2011-11-15 | 2011-11-15 | Medicine for lowering transplant renal arterial resistance index |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103852762A CN102441093A (en) | 2011-11-15 | 2011-11-15 | Medicine for lowering transplant renal arterial resistance index |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102441093A true CN102441093A (en) | 2012-05-09 |
Family
ID=46004353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103852762A Pending CN102441093A (en) | 2011-11-15 | 2011-11-15 | Medicine for lowering transplant renal arterial resistance index |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102441093A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030152651A1 (en) * | 2000-12-21 | 2003-08-14 | Tianjin Tasly Pharmaceutical Co., Ltd., China | Herbal composition for angina pectoris, method to prepare same and uses thereof |
| CN1526437A (en) * | 2003-09-19 | 2004-09-08 | 梁艳龙 | Medicine for treating uraemia |
| US20050037094A1 (en) * | 2003-07-31 | 2005-02-17 | Xijun Yan | Composition for heart disease, its active ingredients, method to prepare same and uses thereof |
| CN101152414A (en) * | 2007-09-30 | 2008-04-02 | 甘志球 | Traditional Chinese medicine preparation for treating chronic nephritis and nephrotic syndrome |
-
2011
- 2011-11-15 CN CN2011103852762A patent/CN102441093A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030152651A1 (en) * | 2000-12-21 | 2003-08-14 | Tianjin Tasly Pharmaceutical Co., Ltd., China | Herbal composition for angina pectoris, method to prepare same and uses thereof |
| US20050037094A1 (en) * | 2003-07-31 | 2005-02-17 | Xijun Yan | Composition for heart disease, its active ingredients, method to prepare same and uses thereof |
| CN1526437A (en) * | 2003-09-19 | 2004-09-08 | 梁艳龙 | Medicine for treating uraemia |
| CN101152414A (en) * | 2007-09-30 | 2008-04-02 | 甘志球 | Traditional Chinese medicine preparation for treating chronic nephritis and nephrotic syndrome |
Non-Patent Citations (3)
| Title |
|---|
| 丁晨光等: "茯苓素预防大鼠肾移植急性排斥性反应的实验研究", 《中国中西医结合杂志》 * |
| 洪用森等: "肾移植中的中医药应用", 《中医杂志》 * |
| 韩冰等: "银屑病辩证论治体会", 《河北中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103142865A (en) | Traditional Chinese medicine for treating hypertension | |
| CN101804189B (en) | Drug for treating primary dysmenorrhea | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN102526613B (en) | Medicament for treating allergic cutaneous vasculitis | |
| CN103495103B (en) | Medicament for promoting digestion and strengthening spleen | |
| CN103007237B (en) | Medicine for treating idiopathic thrombocytopenic purpura (ITP) | |
| CN101850071A (en) | Chinese medicament for treating chronic nephritis | |
| CN104435545A (en) | Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning | |
| CN102441093A (en) | Medicine for lowering transplant renal arterial resistance index | |
| CN102552570B (en) | Medicine for treating acra necrosis after bone trauma | |
| CN102512589B (en) | Medicine for treating early sudden deafness | |
| CN102836347A (en) | Traditional Chinese medicine for treating tinnitus | |
| CN102552569B (en) | Medicine for treating renal artery type arteritis | |
| CN102512546B (en) | Traditional Chinese medicine used for esophageal cancer patients refusing surgery | |
| CN102406875A (en) | Drug for treating endometriosis interna | |
| CN104510827A (en) | Traditional Chinese medicine for treating acne | |
| CN102363021A (en) | Chinese medicine for treating cervical disc retrogression | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
| CN103301261A (en) | Medicine for treating transplant kidney main renal venous stenosis | |
| CN102935173A (en) | Medicament for treating agranulocytosis in combination with mycotic infection of hemopathic patients | |
| CN103479956A (en) | Preparation method of traditional Chinese medicine with function of reinforcing spleen to promote digestion | |
| CN102973803A (en) | Drug for treating hematopathy primary thrombocytopenic purpura | |
| CN102727847A (en) | Preparation method for Chinese herbal lotion used for treating excessive-drinking caused trichomonas vaginitis | |
| CN102657753A (en) | Chinese traditional medicine preparation for treating rheumatoid leg spasm | |
| CN102657813A (en) | Medicament for treating chronic leg ulcers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120509 |